ArticleMicrobial cell factories2025
Novel transcription factor regulating cellulase expression and growth improvement in cellulolytic fungi.
Article in Microbial cell factories, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundTalaromyces sp., as powerful cellulolytic fungi, display a nearly complete enzymatic system, which exhibits a complex regulatory system involving multiple transcription factors to control the expression of cellulase genes. However, there are fewer studies on the transcriptional regulatory factors of cellulase expression in Talaromyces sp. This study provides a basis for in-depth analysis of the transcription regulatory mechanism of Talaromyces endophyticus for cellulase expression, offering new ways for the preparation of fermented sugars using straw resources to produce high value-added products and biofuels.
resultsIn this study, a novel transcription factor was investigated for T. endophyticus NEAU-6 which was a high cellulase-producing strain. Results revealed that TeSrdA was nuclear protein, which was stably expressed in the nucleus. TeSrdA deletion caused a remarkable increase of the activities of FPase (121.1%), CMCase (36.6%), pNPCase (97.0%), β-glucosidase (75.1%) and Xylanase (98.4%). Microscopic analysis showed that ΔTeSrdA strains increased the length of the hyphae and the number of branching. Notably, TeSrdA deletion could accelerated the microbial growth, which was unlike most studies in which deletion of transcription factor led to the reduction of cell growth. Quantitative reverse transcription polymerase chain reaction (RT-qPCR) analyses revealed that the expression of eg7A, cbh6A, bgl3A, xyl11A genes was up-regulated obviously in the ΔTeSrdA strain. Through Electrophoretic mobility shift assays (EMSA), we further discovered that the transcription factor TeSrdA regulated the transcription of eg7A, cbh6A, cbh6B, bgl3A, xyl11A and xyl11B by directly binding to the promoters of these enzyme genes, thereby repressing the cellulase production.
conclusionsTeSrdA plays an important role by increasing hyphal branching, accelerating strain growth, and promoting cellulase and hemicellulase production. The novel transcription factor TeSrdA is of great significance for studying the transcriptional regulatory network related to enzyme production and growth of strains in Talaromyces sp.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.